Find clinical trials for Adenocarcinoma in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Adenocarcinoma trials near New Haven, CT, USA:
(MMRp)/microsatellite stable (MSS) locally advanced rectal adenocarcinoma. The investigators will also find out whether BOT/BAL is an effect...
Phase 2
Commack, New York, United States and 6 other locations
(PK), and efficacy of relacorilant in combination with nab-paclitaxel and gemcitabine in chemotherapy-naïve patients with metastatic pancreatic adenocarcinoma...
Phase 2
Shirley, New York, United States and 14 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.
Phase 3
Hartford, Connecticut, United States of America and 59 other locations
The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma...
Phase 1
New Haven, Connecticut, United States and 8 other locations
(CLDN18.2)-positive, human epidermal growth factor receptor 2 (HER2)-negative, gastric, gastroesophageal junction (GEJ), and esophageal adenocarcinoma...
Phase 3
New Haven, Connecticut, United States and 284 other locations
personalized hyperthermic intraperitoneal chemotherapy (HIPEC) regimens to patients with peritoneal metastasis (PM) from high-grade appendiceal adenocarcinomas...
New Haven, Connecticut, United States
and practical (feasible) before surgical removal (resection) of lung adenocarcinoma (ADC). The researchers will also look at how the treatme...
Phase 1
Commack, New York, United States and 6 other locations
with locally advanced or borderline resectable pancreatic ductal adenocarcinoma (PDAC) before surgery. This type of treatment approach is ca...
Phase 2
Commack, New York, United States and 6 other locations
This study will test a new personalized treatment approach for patients with stomach or esophageal cancer. It will take place in two stages and aims...
Phase 2
New Haven, Connecticut, United States and 2 other locations
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
New Haven, Connecticut, United States and 118 other locations
Clinical trials
Research sites
Resources
Legal